A share price of Lifecore Biomedical Inc [LFCR] is currently trading at $7.00, up 4.17%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The LFCR shares have gain 4.32% over the last week, with a monthly amount glided 9.72%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Craig Hallum started tracking the stock with Buy rating on September 05, 2024, and set its price target to $8. On August 28, 2024, downgrade downgraded it’s rating to Mkt Perform. Stephens downgraded its rating to a Equal-Weight and decreased its price target to $2 on March 20, 2023.
Lifecore Biomedical Inc experienced fluctuations in its stock price throughout the past year between $3.68 and $7.99. Currently, Wall Street analysts expect the stock to reach $6.5 within the next 12 months. Lifecore Biomedical Inc [NASDAQ: LFCR] shares were valued at $7.00 at the most recent close of the market. An investor can expect a potential drop of -7.14% based on the average LFCR price forecast.
Analyzing the LFCR fundamentals
Trailing Twelve Months sales for Lifecore Biomedical Inc [NASDAQ:LFCR] were 130.31M which represents -1.54% decline. Gross Profit Margin for this corporation currently stands at 0.33% with Operating Profit Margin at -0.15%, Pretax Profit Margin comes in at -0.34%, and Net Profit Margin reading is -0.34%. To continue investigating profitability, this company’s Return on Assets is posted at -0.19, Equity is -2.64 and Total Capital is -0.1. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of58.48.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.64 points at the first support level, and at 6.29 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.18, and for the 2nd resistance point, it is at 7.36.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Lifecore Biomedical Inc [NASDAQ:LFCR] is 2.71. Also, the Quick Ratio is 1.59, while the Cash Ratio stands at 0.17. Considering the valuation of this stock, the price to sales ratio is 1.99, the price to book ratio is 116.28.
Transactions by insiders
Recent insider trading involved English Aron R., 10% Owner, that happened on May 13 ’25 when 12334.0 shares were sold. 10% Owner, English Aron R. completed a deal on May 12 ’25 to sell 45698.0 shares. Meanwhile, 10% Owner English Aron R. sold 5098.0 shares on May 08 ’25.
